col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


43 Ergebisse       Seite 1

 [1] 
MDPI AG: Antibodies
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―28 Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein Alexandra Rak, Ekaterina Bazhenova, Polina Prokopenko, Victoria Matyushenko, Yana Orshanskaya, Konstantin V. Sivak, et al. (+3)
2 [GO] 2025―Mai―16 Neutralization of the Pandemic Influenza A/H1N1 Virus with Lama glama Humanized Nanobodies (VHH) Zeila Yazmín Páez-Hernández, Jose Luis Stephano-Hornedo, Jose Alberto Bolaños-Prats, Iván Córdova-Guerrero, Mariana Macías-Alonso, Joaquín G. Marrero, et al. (+2)
3 [GO] 2025―Mrz―28 Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display Platform Oscar Chi-Chien Pan, Sean Miller, Ruchin Patel, Shreya Mukhopadhyay, Giancarlo Sarullo, Gwenny Go, et al. (+11)
4 [GO] 2025―Mrz―07 The Use of Heterologous Antigens for Biopanning Enables the Selection of Broadly Neutralizing Nanobodies Against SARS-CoV-2 Vazirbek S. Aripov, Anna V. Zaykovskaya, Ludmila V. Mechetina, Alexander M. Najakshin, Alexander A. Bondar, Sergey G. Arkhipov, et al. (+9)
5 [GO] 2025―Feb―05 Evaluation of SARS-CoV-2 Antibody Response Between Paired Fingerprick (HemaPEN®) and Venepuncture Collected Samples in Children and Adults Nadia Mazarakis, Zheng Quan Toh, Jill Nguyen, Rachel A. Higgins, James Rudge, Belinda Whittle, et al. (+7)
6 [GO] 2024―Sep―24 SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients Jan Basri Adiprasito, Tobias Nowacki, Richard Vollenberg, Jörn Arne Meier, Florian Rennebaum, Tina Schomacher, et al. (+4)
7 [GO] 2024―Sep―02 Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection Ammar Abdurrahman Hasyim, Akihiko Sakamoto, Kyouhei Yamagata, Kartika Hardianti Zainal, Desi Dwirosalia Ningsih Suparman, Ika Yustisia, et al. (+5)
8 [GO] 2024―Aug―06 The Seraph 100® Microbind Affinity Blood Filter Does Not Alter Levels of Circulating or Mucosal Antibodies in Critical COVID-19 Patients Tonia L. Conner, Pooja Vir, Eric D. Laing, Ian J. Stewart, Edward Mitre, Kathleen P. Pratt
9 [GO] 2024―Mai―14 Humoral Immunity across the SARS-CoV-2 Spike after Sputnik V (Gam-COVID-Vac) Vaccination Alejandro Cornejo, Christopher Franco, Mariajose Rodriguez-Nuñez, Alexis García, Inirida Belisario, Soriuska Mayora, et al. (+10)
10 [GO] 2024―Mai―07 Structural and Functional Characterization of Medicinal Plants as Selective Antibodies towards Therapy of COVID-19 Symptoms Fatemeh Mollaamin
11 [GO] 2024―Feb―08 SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination Nicola Manfrini, Samuele Notarbartolo, Renata Grifantini, Elisa Pesce
12 [GO] 2024―Jan―08 Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults Andrea Padoan, Chiara Cosma, Costanza Di Chiara, Giulia Furlan, Stefano Gastaldo, Ilaria Talli, et al. (+4)
13 [GO] 2024―Jan―05 Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein Emanuela D’Acunto, Alessia Muzi, Silvia Marchese, Lorena Donnici, Valerio Chiarini, Federica Bucci, et al. (+23)
14 [GO] 2023―Dez―11 Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations Olga N. Shaprova, Daniil V. Shanshin, Evgeniia A. Kolosova, Sophia S. Borisevich, Artem A. Soroka, Iuliia A. Merkuleva, et al. (+8)
15 [GO] 2023―Dez―07 Neutralization of Different Variants of SARS-CoV-2 by a F(ab′)2 Preparation from Sera of Horses Immunized with the Viral Receptor Binding Domain Mariajosé Rodriguez-Nuñez, Mariana del Valle Cepeda, Carlos Bello, Miguel Angel Lopez, Yoneira Sulbaran, Carmen Luisa Loureiro, et al. (+4)
16 [GO] 2023―Dez―01 Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy Stefania Paduano, Michele Granata, Sara Turchi, Alberto Modenese, Pasquale Galante, Alessandro Poggi, et al. (+8)
17 [GO] 2023―Sep―25 Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Snjezana Kovac, Ema Borko, Maja Bogdanic, Gorana Miletic, et al. (+7)
18 [GO] 2023―Sep―21 Comparison between Neutralization Capacity of Antibodies Elicited by COVID-19 Natural Infection and Vaccination in Indonesia: A Prospective Cohort Sitti Nurisyah, Mitsuhiro Iyori, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, Hinata Hashimoto, Kyouhei Yamagata, et al. (+10)
19 [GO] 2023―Jul―28 Psychiatric Symptoms in Acute and Persisting Forms of COVID-19 Associated with Neural Autoantibodies Niels Hansen
20 [GO] 2023―Jun―16 RDE Treatment Prevents Non-Specific Detection of SARS-CoV-2- and Influenza-Specific IgG Antibodies in Heat-Inactivated Serum Samples Arina Goshina, Victoria Matyushenko, Daria Mezhenskaya, Alexandra Rak, Anastasia Katelnikova, Denis Gusev, et al. (+2)
21 [GO] 2023―Mai―25 Serological Response to SARS-CoV-2 Vaccine in Hemodialyzed Patients and the Association with Later COVID-19 Positivity Vedran Premuzic, Ranko Stevanovic, Tatjana Vilibic-Cavlek, Maja Sirovica, Sara Stalman, Maja Bogdanic, et al. (+15)
22 [GO] 2023―Mai―11 Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test Tatjana Vilibic-Cavlek, Maja Bogdanic, Ema Borko, Zeljka Hruskar, Denis Zilic, Thomas Ferenc, et al. (+5)
23 [GO] 2023―Feb―27 Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity Yulia Desheva, Anna Lerner, Tamara Shvedova, Olga Kopteva, Polina Kudar, Irina Koroleva, et al. (+2)
24 [GO] 2023―Feb―24 Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation Nabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, Suprabhat Mukherjee
25 [GO] 2023―Feb―01 Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections Luis Martinez-Sobrido, James J. Kobie
26 [GO] 2023―Jan―16 Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness Janet M. Daly, Theam Soon Lim, Kevin C. Gough
27 [GO] 2023―Jan―12 A Review of the Currently Available Antibody Therapy for the Treatment of Coronavirus Disease 2019 (COVID-19) Kristin Widyasari, Jinnam Kim
28 [GO] 2022―Dez―27 The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave Atefeh Vaezi, Hamed Fakhim, Saeed Abbasi, Soraya Masoudi, Mahnaz Hosseini Rizi, Shaghayegh Haghjooy Javanmard
29 [GO] 2022―Dez―13 SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform Stefan Hirschberg, Hannes Bauer, Julian Kamhieh-Milz, Frauke Ringel, Christoph Harms, Omar Kamal Eddin, et al. (+3)
30 [GO] 2022―Okt―25 Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites Yekbun Adiguzel, Yehuda Shoenfeld
31 [GO] 2022―Mai―27 Kinetics of the Neutralizing and Spike SARS-CoV-2 Antibodies following the Sinovac Inactivated Virus Vaccine Compared to the Pfizer mRNA Vaccine in Singapore Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, et al. (+4)
32 [GO] 2022―Mai―13 Long-Term Immunity and Antibody Response: Challenges for Developing Efficient COVID-19 Vaccines Mohammad Reza Sepand, Banafsheh Bigdelou, Jim Q. Ho, Mohammad Sharaf, Alexis J. Lannigan, Ian M. Sullivan, et al. (+8)
33 [GO] 2022―Apr―02 Cellular, Antibody and Cytokine Pathways in Children with Acute SARS-CoV-2 Infection and MIS-C-Can We Match the Puzzle? Snezhina Lazova, Yulia Dimitrova, Diana Hristova, Iren Tzotcheva, Tsvetelina Velikova
34 [GO] 2022―Feb―11 Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library Ivette Mendoza-Salazar, Keyla M. Gómez-Castellano, Edith González-González, Ramsés Gamboa-Suasnavart, Stefany D. Rodríguez-Luna, Giovanni Santiago-Casas, et al. (+3)
35 [GO] 2022―Jan―21 Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS Emmanuel J. Favaloro, Leonardo Pasalic, Giuseppe Lippi
36 [GO] 2021―Dez―20 Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing Chin-Shern Lau, Tar-Choon Aw
37 [GO] 2021―Nov―08 Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies Tal Noy-Porat, Avishay Edri, Ron Alcalay, Efi Makdasi, David Gur, Moshe Aftalion, et al. (+12)
38 [GO] 2021―Jul―06 Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization Rut Valgardsdottir, Irene Cattaneo, Gavino Napolitano, Annibale Raglio, Orietta Spinelli, Silvia Salmoiraghi, et al. (+5)
39 [GO] 2021―Jun―02 Immune Response to SARS-CoV-2 in an Asymptomatic Pediatric Allergic Cohort Nathan L. Marsteller, Diana J. Fregoso, Tricia L. Morphew, Inderpal S. Randhawa
40 [GO] 2021―Jan―11 Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets Lokesh Agrawal, Thanasis Poullikkas, Scott Eisenhower, Carlo Monsanto, Ranjith Kumar Bakku, Min-Hua Chen, Rajkumar Singh Kalra
41 [GO] 2020―Okt―12 Structural Features and PF4 Functions that Occur in Heparin-Induced Thrombocytopenia (HIT) Complicated by COVID-19 Zheng Cai, Mark I. Greene, Zhiqiang Zhu, Hongtao Zhang
42 [GO] 2020―Aug―17 The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection Francis Okeke, Anjali Mone, Arun Swaminath
43 [GO] 2020―Jul―16 From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry Darja Kanduc
 [1] 

43 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec